Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.

Georgina Nakafero,Matthew J Grainge,Hywel C Williams,Tim Card,Maarten W Taal,Guruprasad P Aithal,Christopher P Fox,Christian D Mallen,Danielle A van der Windt,Matthew D Stevenson,Richard D Riley,Abhishek Abhishek

BMJ (Clinical research ed.)（2023）

引用 2|浏览12

暂无评分

摘要

A prognostic model was developed and validated that uses information collected during routine clinical care and may be used to risk stratify the frequency of monitoring blood test during long term methotrexate treatment.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要